Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breast cancer patients in mozambique get a guide: study tests if navigation speeds up treatment

NCT ID NCT06257888

Knowledge-focused Sponsor: Renato Cagnacci Neto Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether patient navigators can help women with breast cancer in Mozambique start treatment sooner. Ninety women received support from trained navigators from admission to their first treatment. Researchers measured time delays and survival rates compared to past patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
patient navigation
What this could lead to
If successful, this could show that patient navigation reduces delays in breast cancer treatment and improves survival in low-resource settings.
What could go wrong
This is an observational study with a small group of 90 women and no control group, so results may not be generalizable. The intervention is support-based, not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

90 people

The number who actually took part.

Started

Mar 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

we will recruit all female primary breast cancer patients (invasive or in situ) admitted for treatment at HCM during a 12 month period

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * female * 18 years and older * will undergo breast cancer treatment at HCM * consent to participate Exclusion Criteria: * male * less than18 years of age * history of other previous malignancies (including breast cancer) * history of breast cancer treatment initiated elsewhere * lack of consent to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast neoplasm malignant primary are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast neoplasm malignant primary

Contacts and locations

Locations

  • Hospital Central de Maputo

    Maputo, Cidade de Maputo, 010103, Mozambique

More trials for these conditions

Other studies related to the condition(s) this trial covers.